Immunologic staging of prostatic carcinoma: three years of experience.
The immunological specificity of prostatic acid phosphatase has been demonstrated previously in the laboratory and used in a small number of patients. Our findings in 96 patients using gel immunodiffusion with an acid phosphatase antiserum in the study of bone marrow aspirates and lymph nodes are reported.
D000135:Acid Phosphatase / Q000276:immunology*; D000368:Aged; D001853:Bone Marrow / Q000201:enzymology / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008198:Lymph Nodes / Q000201:enzymology / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000201:enzymology / Q000276:immunology / Q000473:pathology*
D007106:Immune Sera; D000135:Acid Phosphatase